All settlements
Claims not open yetProof TBD

CeraVe

CeraVe Benzene Lawsuit Over Acne Cleansers and Effaclar Duo

Shoppers who bought CeraVe acne cleansers from 2019 to 2024 may qualify if the benzene class action lawsuit succeeds. Check eligibility and claim details.

Potential payment
Up to $500

Subject to eligibility and claim terms.

Claim deadline
TBD
Proof requirement
TBD

Eligibility

Who may qualify?

Check the covered dates, products, locations, and other official terms before you file.

  • You bought one of the named products. CeraVe Acne Foaming Cream Cleanser, CeraVe Acne Foaming Cream Wash, La Roche-Posay Effaclar Duo
  • Your purchases occurred within the past four years.
  • You used the products regularly, as directed, for personal or household skincare.
  • You would have avoided the product, or paid significantly less, had you known about the potential for benzene degradation.

Case overview

What is the CeraVe case about?

L'Oréal USA's two flagship skincare brands, CeraVe and La Roche-Posay, are facing roughly six class-action lawsuits alleging their acne treatments can contain benzene, a known human carcinogen. The problem stems from benzoyl peroxide, the active acne-fighting ingredient, which can break down into benzene when exposed to normal heat and storage conditions. Independent lab Valisure found benzene levels of 5 to 12 ppm in CeraVe acne cleansers, as much as six times higher than the FDA's 2 ppm limit. Several of the lawsuits go further, alleging the products also contain PFAS ('forever chemicals') and accusing L'Oréal of deceptive marketing for promoting the line as safe, gentle, and 'developed with dermatologists' while allegedly staying quiet about contamination risks. The first suit, filed in Hawaii in February 2024, focused on La Roche-Posay's Effaclar Duo, the same product L'Oréal voluntarily pulled from U.S. shelves in March 2025. The cases remain active, with pre-trial motions, discovery, and class-certification proceedings currently underway; no settlement has yet been reached.

Case details

Company
CeraVe (a subsidiary/brand of L’Oréal USA, Inc.)

Questions people ask

Frequently asked questions

How much is the CeraVe case payout?

The listed potential payment is Up to $500. Final amounts depend on the number of valid claims and the administrator's terms.

Who qualifies for the CeraVe case?

Key eligibility criteria include: You bought one of the named products. CeraVe Acne Foaming Cream Cleanser, CeraVe Acne Foaming Cream Wash, La Roche-Posay Effaclar Duo; Your purchases occurred within the past four years; You used the products regularly, as directed, for personal or household skincare; You would have avoided the product, or paid significantly less, had you known about the potential for benzene degradation. Always confirm the full class definition with the official source before filing.

Is the CeraVe case open for claims?

Not yet. No claim process is currently open. TapClaim monitors official updates to this case.

Settlement administrator and official sources

  • Listing verification
    Last checked Sep 26, 2026